Precipio Inc
NASDAQ:PRPO

Watchlist Manager
Precipio Inc Logo
Precipio Inc
NASDAQ:PRPO
Watchlist
Price: 24.55 USD 0.7% Market Closed
Market Cap: $43m

Operating Margin

-9.1%
Current
Improving
by 40.7%
vs 3-y average of -49.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-9.1%
=
Operating Income
$-2.1m
/
Revenue
$22.8m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-9.1%
=
Operating Income
$-2.1m
/
Revenue
$22.8m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Precipio Inc
NASDAQ:PRPO
42.9m USD
Loading...
US
CVS Health Corp
NYSE:CVS
105.4B USD
Loading...
US
Cigna Group
XMUN:CGN
63.4B EUR
Loading...
US
Cigna Corp
NYSE:CI
74.4B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.2B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.9B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.1B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.1B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.3B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
US
DaVita Inc
NYSE:DVA
7.7B USD
Loading...

Market Distribution

Lower than 72% of companies in the United States of America
Percentile
28th
Based on 14 112 companies
28th percentile
-9.1%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Precipio Inc
Glance View

Market Cap
43m USD
Industry
Health Care

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. The company is headquartered in Omaha, Nebraska and currently employs 55 full-time employees. The company went IPO on 2000-07-18. The firm is focused on developing various technologies including IV-Cell, HemeScreen and ICE-COLD-PCR (ICP). The IV-Cell is a cell culture media that addresses the problem of selective and serial culturing. IV-Cell is a media that enables culturing of all four hematopoietic cell lineages, which include myeloid cells, B-cells, T-cells and plasma cells. The diagnostic process of hematopoietic diseases involves chromosomal analysis by conducting cell-culture-based tests in a cytogenetics laboratory to imitate in-vivo conditions. HemeScreen technology was developed by the Company targeting Myeloproliferative Neoplasms (MPN), which has evolved into a suite of robust genetic diagnostic panels. ICP technology was developed at Harvard and is licensed exclusively by Dana-Farber. Its laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha.

PRPO Intrinsic Value
13.49 USD
Overvaluation 45%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-9.1%
=
Operating Income
$-2.1m
/
Revenue
$22.8m
What is Precipio Inc's current Operating Margin?

The current Operating Margin for Precipio Inc is -9.1%, which is above its 3-year median of -49.8%.

How has Operating Margin changed over time?

Over the last 3 years, Precipio Inc’s Operating Margin has increased from -141.3% to -9.1%. During this period, it reached a low of -141.3% on Sep 30, 2022 and a high of -9.1% on Sep 30, 2025.

Back to Top